Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylcyclopentane SCHEMBL11593657 | 0.97 | CA12 (0.39) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL22495741 | 0.88 | ACHE (0.42) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL28353928 | 0.87 | CA12 (0.38) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL15617310 | 0.85 | CA12 (0.37) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL14999117 | 0.85 | CA12 (0.37) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL14845770 | 0.85 | CA12 (0.37) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL15457741 | 0.85 | CA12 (0.37) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL17570322 | 0.81 | CA12 (0.33) | CA12CA7CA14CA9KMT2A | |
| SCHEMBL8216679 | 0.81 | — | — | |
| Cycloheptane SCHEMBL23885013 | 0.80 | ACHE (0.43) | CA12CA7CA14CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120261-A | Preparation method of 3- [ (4-sulfadiazine-1-yl) methyl ] benzoic acid compound | 浙大宁波理工学院 | 2023-05-16 | — | — | CN | claimed |
| US-20250051343-A1 | INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES | Isosterix, Inc. | 2025-02-13 | — | — | US | disclosed |
| EP-4499609-A1 | INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES | Isosterix, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| US-12187732-B2 | Inhibitors of the myst family of lysine acetyl transferases | Isosterix, Inc. (US) | 2025-01-07 | — | — | US | disclosed |
| WO-2023192817-A9 | INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES | Isosterix, Inc. (US) | 2024-10-03 | — | — | WO | disclosed |
| US-11976075-B2 | Inhibitors of the MYST family of lysine acetyl transferases | Isosterix, Inc. | 2024-05-07 | — | — | US | disclosed |
| CN-116120261-B | Preparation method of 3- [ (4-sulfadiazine-1-yl) methyl ] benzoic acid compound | 浙大宁波理工学院 | 2024-01-23 | — | — | CN | disclosed |
| US-20230416260-A1 | Inhibitors of the MYST Family of Lysine Acetyl Transferases | Isosterix, Inc. | 2023-12-28 | — | — | US | disclosed |
| WO-2023192817-A1 | INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES | Isosterix, Inc. (US) | 2023-10-05 | — | — | WO | disclosed |
| CN-116120261-A | Preparation method of 3- [ (4-sulfadiazine-1-yl) methyl ] benzoic acid compound | 浙大宁波理工学院 | 2023-05-16 | — | — | CN | disclosed |
| CN-101641348-B | Imidazolidinone derivatives | HOFFMANN LA ROCHE | 2014-09-10 | — | — | CN | disclosed |
| EP-2576520-A1 | RADIOLABELED COMPOUNDS AND METHODS THEREOF | GE Healthcare UK Limited (GB) | 2013-04-10 | — | — | EP | disclosed |
| US-20130064770-A1 | RADIOLABELED COMPOUNDS AND METHODS THEREOF | GE HEALTHCARE LIMITED (GB) | 2013-03-14 | — | — | US | disclosed |
| CN-102918031-A | Radiolabeled compounds and methods thereof | GE HEALTHCARE LTD | 2013-02-06 | — | — | CN | disclosed |
| WO-2011150183-A1 | RADIOLABELED COMPOUNDS AND METHODS THEREOF | GE HEALTHCARE LIMITED (GB) | 2011-12-01 | — | — | WO | disclosed |
| CN-101641348-A | Imidazolidinone derivatives | HOFFMANN LA ROCHE CH | 2010-02-03 | — | — | CN | disclosed |
| CN-101400651-A | Diaryl piperidines as CB1 modulators | SCHERING CORP (US) | 2009-04-01 | — | — | CN | disclosed |
| CN-1756551-A | New arylpiperazinyl compounds | PREDIX PHARMACEUTICALS HOLDING (US) | 2006-04-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051343-A1 | INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES | KAT6A, KAT6B, KAT2A | CA12 4272/4885CA7 3349/4885CA14 4437/4885 |
| US-20230416260-A1 | Inhibitors of the MYST Family of Lysine Acetyl Transferases | KAT6A, KAT6B, KAT2A | CA12 4272/4885CA7 3349/4885CA14 4437/4885 |
| US-12187732-B2 | Inhibitors of the myst family of lysine acetyl transferases | KAT6A, KAT6B, KAT2A | CA12 4272/4885CA7 3349/4885CA14 4437/4885 |
| US-20130064770-A1 | RADIOLABELED COMPOUNDS AND METHODS THEREOF | HTR5A, HTR3B, HTR1A | CA12 1957/4885CA7 2985/4885CA14 1493/4885 |
| US-11976075-B2 | Inhibitors of the MYST family of lysine acetyl transferases | KAT6A, KAT6B, KAT2A | CA12 4272/4885CA7 3349/4885CA14 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.